DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 70 filers reported holding DICE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,746,500 | -43.0% | 410,000 | -37.9% | 1.68% | -30.3% |
| Q4 2022 | $20,592,000 | -6.4% | 660,000 | -39.2% | 2.41% | -10.9% |
| Q3 2022 | $22,009,000 | +43.9% | 1,085,251 | +10.1% | 2.71% | -3.5% |
| Q2 2022 | $15,291,000 | -42.3% | 985,251 | -28.9% | 2.80% | -18.4% |
| Q1 2022 | $26,500,000 | -37.1% | 1,385,251 | -16.8% | 3.44% | -20.9% |
| Q4 2021 | $42,122,000 | +10.9% | 1,664,251 | +43.4% | 4.34% | +58.5% |
| Q3 2021 | $37,998,000 | – | 1,160,251 | – | 2.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $62,993,000 | 33.95% |
| Sands Capital Ventures, LLC | 3,148,970 | $60,240,000 | 12.58% |
| OUP Management Co., LLC | 536,693 | $10,267,000 | 7.82% |
| New Leaf Venture Partners, L.L.C. | 556,693 | $10,650,000 | 5.25% |
| Logos Global Management LP | 1,385,251 | $26,500,000 | 3.44% |
| Soleus Capital Management, L.P. | 983,994 | $18,824,000 | 2.43% |
| RA Capital Management | 5,208,911 | $99,646,000 | 2.17% |
| Deep Track Capital, LP | 1,250,000 | $23,913,000 | 1.53% |
| Samsara BioCapital, LLC | 228,466 | $4,371,000 | 1.10% |
| HighVista Strategies LLC | 48,960 | $937,000 | 0.60% |